Companies › JAZZ

JAZZ PHARMACEUTICALS PLC (JAZZ)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001232524 · EDGAR filings · Updated 2026-07-24

JAZZ PHARMACEUTICALS PLC (JAZZ) has reported institutional ownership of 103.6%, with 568 institutional managers holding positions valued at $12.3B per the latest 13F reporting period.

Filings this week (1)

• 2026-07-24 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-14 — DEFA14A filed
• 2026-07-06 — Insider transaction reported (Form 4)
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-02 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, JAZZ PHARMACEUTICALS PLC has 568 institutional holders and institutional ownership of 103.6%.

Insider activity

Insiders reported 118 transactions (4 buys, 47 sells) across 20 reporting insiders, with a net reported value of −$28.4M.

Related companies

GUARDANT HEALTH INC (GH) · ASCENDIS PHARMA A/S SPONSORED (ASND) · MADRIGAL PHARMACEUTICALS INC (MDGL) · ALIGN TECHNOLOGY INC (ALGN) · MEDPACE HLDGS INC (MEDP) · PENUMBRA INC (PEN)